Kancera AB, of Stockholm, Sweden, said it has identified, in collaboration with scientists at the Karolinska Institute, active compounds that effectively kill pancreatic cancer cells. Results showed that the amount of activated ROR in aggressive cancer cells from pancreas is high, and that active compounds against ROR effectively killed those cells within 48 hours from the start of experimental treatment.